IL129421A0 - Secondary cataract inhibitor - Google Patents
Secondary cataract inhibitorInfo
- Publication number
- IL129421A0 IL129421A0 IL12942197A IL12942197A IL129421A0 IL 129421 A0 IL129421 A0 IL 129421A0 IL 12942197 A IL12942197 A IL 12942197A IL 12942197 A IL12942197 A IL 12942197A IL 129421 A0 IL129421 A0 IL 129421A0
- Authority
- IL
- Israel
- Prior art keywords
- secondary cataract
- inhibitor
- cataract inhibitor
- cataract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30695296 | 1996-10-14 | ||
| PCT/JP1997/003630 WO1998016214A1 (fr) | 1996-10-14 | 1997-10-09 | Inhibiteur de la cataracte secondaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL129421A0 true IL129421A0 (en) | 2000-02-17 |
Family
ID=17963256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12942197A IL129421A0 (en) | 1996-10-14 | 1997-10-09 | Secondary cataract inhibitor |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6376543B1 (de) |
| EP (1) | EP0958815A4 (de) |
| KR (1) | KR20000049136A (de) |
| CN (1) | CN1111403C (de) |
| AU (1) | AU745028B2 (de) |
| BR (1) | BR9712308A (de) |
| CA (1) | CA2267320A1 (de) |
| CZ (1) | CZ127999A3 (de) |
| EA (1) | EA001745B1 (de) |
| HU (1) | HUP9904617A3 (de) |
| IL (1) | IL129421A0 (de) |
| NO (1) | NO991627L (de) |
| NZ (1) | NZ335042A (de) |
| WO (1) | WO1998016214A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ500300A (en) * | 1997-04-18 | 2001-01-26 | Kissei Pharmaceutical | Compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid for the treatment of excessive proliferation of retinal pigment epithelial cells |
| US20060166879A1 (en) * | 2002-12-20 | 2006-07-27 | Chakshu Research Inc | Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| US20060172972A1 (en) * | 2002-12-20 | 2006-08-03 | Chakshu Research Inc | Formulation and method for administration of ophthalmologically active agents |
| US20040137068A1 (en) * | 2002-12-20 | 2004-07-15 | Rajiv Bhushan | Ophthalmic formulation for the prevention and treatment of adverse ocular conditions, particularly those associated with the aging eye |
| US20060177430A1 (en) * | 2002-12-20 | 2006-08-10 | Chakshu Research Inc | Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| US20050106230A1 (en) * | 2003-11-17 | 2005-05-19 | Young Janel E. | Drug-enhanced adhesion prevention |
| JP4966019B2 (ja) * | 2005-01-06 | 2012-07-04 | キッセイ薬品工業株式会社 | 慢性移植片対宿主症におけるドライアイの予防および治療剤 |
| CA2615231A1 (en) * | 2005-07-15 | 2007-01-25 | Chakshu Research Inc. | Prevention and treatment of ophthalmic complications of diabetes |
| WO2008069961A1 (en) * | 2006-12-01 | 2008-06-12 | Wake Forest University Health Sciences | Medical devices incorporating collagen inhibitors |
| US8614233B2 (en) | 2007-05-29 | 2013-12-24 | Universite De Montreal | Cinnamoyl inhibitors of transglutaminase |
| NZ597573A (en) * | 2009-07-02 | 2013-10-25 | Oxigene Inc | Combretastatins for prevention of posterior capsule opacification |
| US9844556B2 (en) | 2015-03-25 | 2017-12-19 | Megumi Honjo | Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery |
| RU2622606C1 (ru) * | 2016-08-11 | 2017-06-16 | Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ медикаментозного лечения вторичной катаракты |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07116029B2 (ja) * | 1989-04-04 | 1995-12-13 | キッセイ薬品工業株式会社 | トラニラスト水溶液製剤 |
| FR2693107B1 (fr) * | 1992-07-01 | 1994-09-23 | Chauvin Laboratoire | Moyens pour la prévention de la cataracte secondaire. |
| DE69434617D1 (de) * | 1993-11-19 | 2006-04-06 | Univ Sydney | Verfahren zur prophylaxe oder kontrolle des katarakts |
| EA199800721A1 (ru) * | 1996-02-15 | 1999-02-25 | Киссеи Фармасьютикал Ко., Лтд. | Ингибитор реваскуляризации |
-
1997
- 1997-10-09 BR BR9712308-0A patent/BR9712308A/pt not_active Application Discontinuation
- 1997-10-09 IL IL12942197A patent/IL129421A0/xx unknown
- 1997-10-09 HU HU9904617A patent/HUP9904617A3/hu unknown
- 1997-10-09 KR KR1019990703223A patent/KR20000049136A/ko not_active Application Discontinuation
- 1997-10-09 NZ NZ335042A patent/NZ335042A/xx unknown
- 1997-10-09 CZ CZ991279A patent/CZ127999A3/cs unknown
- 1997-10-09 CA CA002267320A patent/CA2267320A1/en not_active Abandoned
- 1997-10-09 CN CN97198769A patent/CN1111403C/zh not_active Expired - Fee Related
- 1997-10-09 EA EA199900374A patent/EA001745B1/ru not_active IP Right Cessation
- 1997-10-09 AU AU44718/97A patent/AU745028B2/en not_active Ceased
- 1997-10-09 WO PCT/JP1997/003630 patent/WO1998016214A1/ja not_active Application Discontinuation
- 1997-10-09 EP EP97943164A patent/EP0958815A4/de not_active Withdrawn
- 1997-10-09 US US09/269,200 patent/US6376543B1/en not_active Expired - Fee Related
-
1999
- 1999-04-06 NO NO991627A patent/NO991627L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA001745B1 (ru) | 2001-08-27 |
| NO991627L (no) | 1999-06-03 |
| NZ335042A (en) | 2001-01-26 |
| CN1233172A (zh) | 1999-10-27 |
| CZ127999A3 (cs) | 1999-07-14 |
| HUP9904617A2 (hu) | 2000-05-28 |
| BR9712308A (pt) | 1999-08-31 |
| AU4471897A (en) | 1998-05-11 |
| EP0958815A4 (de) | 2001-02-07 |
| AU745028B2 (en) | 2002-03-07 |
| CN1111403C (zh) | 2003-06-18 |
| KR20000049136A (ko) | 2000-07-25 |
| EP0958815A1 (de) | 1999-11-24 |
| US6376543B1 (en) | 2002-04-23 |
| WO1998016214A1 (fr) | 1998-04-23 |
| CA2267320A1 (en) | 1998-04-23 |
| HUP9904617A3 (en) | 2000-07-28 |
| EA199900374A1 (ru) | 1999-12-29 |
| NO991627D0 (no) | 1999-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69533256D1 (en) | Chimäre komplement inhibitor proteine | |
| PL331338A1 (en) | Thiosulphonamidic metaloprotease inhibitors | |
| PL332497A1 (en) | Reflux inhibitor | |
| IL136073A0 (en) | Transformer | |
| GB9624731D0 (en) | Complement inhibitor | |
| EP0894496A4 (de) | Hemmer der gefässneubildung | |
| EP0913404A4 (de) | Differenzierungsinhibitor | |
| IL129421A0 (en) | Secondary cataract inhibitor | |
| PL331244A1 (en) | Polymerisation inhibitor | |
| HU9503783D0 (en) | Squvalen syntetase inhibitors | |
| GB9716848D0 (en) | Incontinence bed-wear | |
| GB2346885B (en) | Phospholipase inhibitor | |
| AU2251195A (en) | Secondary sink | |
| DE69523450D1 (en) | Inhibitor | |
| IL112244A0 (en) | Novel inhibitor | |
| EP0844626A4 (de) | Transformator | |
| GB2331854A9 (en) | Transformer | |
| ZA97601B (en) | Transformer | |
| GB9717893D0 (en) | Inhibitor | |
| GB9707219D0 (en) | Inhibitor | |
| GB9616284D0 (en) | Shock inhibitor | |
| GB9601787D0 (en) | Inhibitors | |
| GB9623742D0 (en) | Inhibitors | |
| GB9602851D0 (en) | HIV intergrase inhibitors | |
| GB9722761D0 (en) | HIV intergrase inhibitors |